Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.
Jung Hoon ShinJi-Yeon KimJung Min OhJeong Eon LeeSeok Won KimSeok Jin NamWon ParkYeon Hee ParkJin Seok AhnYoung-Hyuck ImPublished in: Cancers (2023)
A small subset of patients with HER2+ MBC and metastatic TNBC may be curable with multimodality therapy. Prospective studies integrating clinical and genomic data may identify unique clinicogenomic features of MBC patients who can achieve durable disease control without prolonged chemotherapy.